Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. NewGLAB Pharma CO.,LTD
  6. Summary
    A214870   KR7214870008

NEWGLAB PHARMA CO.,LTD

(A214870)
End-of-day quote Korea Stock Exchange  -  2022-09-29
9410.00 KRW   -.--%
04/05NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
CI
2021NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm
CI
2021NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding
CI
 SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
9700 9610 9420 9410 9410 Last
177695 123618 170889 155146 113629 Volume
-3.48% -0.93% -1.98% -0.11% 0.00% Change
Estimated financial data (e)
Sales 2020 54 417 M 37,9 M 37,9 M
Net income 2020 -22 609 M -15,7 M -15,7 M
Net Debt 2020 14 158 M 9,86 M 9,86 M
P/E ratio 2020 -15,8x
Yield 2020 -
Sales 2021 29 354 M 20,4 M 20,4 M
Net income 2021 -50 511 M -35,2 M -35,2 M
Net Debt 2021 14 581 M 10,2 M 10,2 M
P/E ratio 2021 -6,92x
Yield 2021 -
Capitalization 297 B 207 M 207 M
EV / Sales 2020 7,32x
EV / Sales 2021 12,6x
Nbr of Employees 22
Free-Float 90,5%
More Financials
Company
NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video... 
More about the company
All news about NEWGLAB PHARMA CO.,LTD
04/05NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB..
CI
2021NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding f..
CI
2021NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding
CI
2021NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding
CI
2020NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financ..
CI
2020NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB ..
CI
2019NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding
CI
2019NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding
CI
2019NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index
CI
2019NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financ..
CI
2019An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International.
CI
2019NewGLAB CO.,LTD announced that it has received KRW 10.000001088 billion in funding
CI
2019NewGLAB CO.,LTD announced that it has received KRW 5 billion in funding
CI
2018HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB ..
CI
2018Arenel International Co., Ltd. acquired 13.1% stake in HDPRO Co., Ltd. from NextEye Co...
CI
More news
News in other languages on NEWGLAB PHARMA CO.,LTD

- No features available -

More news
Chart NEWGLAB PHARMA CO.,LTD
Duration : Period :
NewGLAB Pharma CO.,LTD Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Dae-Woo Park Chief Executive Officer & Director
Jae-Sang Jung Independent Director
Jeong-Hwan Yu Independent Director
Yo-Han Lee Independent Director
Jae-Seok Im Director
Sector and Competitors